|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
US4452901A
(en)
|
1980-03-20 |
1984-06-05 |
Ciba-Geigy Corporation |
Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
|
|
DE3169595D1
(en)
|
1980-11-10 |
1985-05-02 |
Gersonde Klaus |
Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
EP0088046B1
(de)
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
|
DE3218121A1
(de)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Arzneimittel zur tumorbehandlung
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
DE3486459D1
(de)
|
1983-09-26 |
1997-12-11 |
Udo Dr Med Ehrenfeld |
Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
|
|
EP0143949B1
(en)
|
1983-11-01 |
1988-10-12 |
TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION |
Pharmaceutical composition containing urokinase
|
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
|
ATE248583T1
(de)
|
1997-09-29 |
2003-09-15 |
Nektar Therapeutics |
In dosierinhalatoren verwendbare, stabilisierte zubereitungen
|
|
US6262096B1
(en)
*
|
1997-11-12 |
2001-07-17 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
US6040321A
(en)
*
|
1997-11-12 |
2000-03-21 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
CA2326389C
(en)
|
1998-04-21 |
2007-01-23 |
Micromet Gesellschaft Fur Biomedizinische Forschung Mbh |
Novel cd19xcd3 specific polypeptides and uses thereof
|
|
GB9823871D0
(en)
*
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
|
MXPA02001498A
(es)
|
1999-08-12 |
2003-07-21 |
Pharmacia & Italia S P A |
Derivados de 3(5)-amino-pirazol, procedimiento para la preparacion de los mismos y usos como agentes antitumorales.
|
|
CA2392576A1
(en)
*
|
1999-11-24 |
2001-05-31 |
Lingyan Wang |
.beta.-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa
|
|
PT1280520E
(pt)
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
|
DZ3398A1
(fr)
|
2000-08-31 |
2002-03-07 |
Pfizer Prod Inc |
Derives pyrazole et leur utilisation comme inhibiteurs des proteines kinases
|
|
DE60208630T2
(de)
|
2001-05-11 |
2006-08-17 |
Pfizer Products Inc., Groton |
Thiazolderivate und ihre Verwendung als cdk-Inhibitoren
|
|
TWI324518B
(en)
|
2001-12-19 |
2010-05-11 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
|
AR059224A1
(es)
*
|
2006-01-31 |
2008-03-19 |
Jerini Ag |
Compuestos para la inhibicion de integrinas y uso de estas
|
|
WO2008046919A2
(en)
|
2006-10-21 |
2008-04-24 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
|
|
JP4616237B2
(ja)
|
2006-11-07 |
2011-01-19 |
日本電信電話株式会社 |
シリコン化合物薄膜の形成方法
|
|
EP2121619A2
(en)
*
|
2006-11-24 |
2009-11-25 |
AC Immune S.A. |
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
|
|
EP2309855A4
(en)
*
|
2008-07-30 |
2012-06-27 |
Oncotherapy Science Inc |
BENZIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3-BETA INHIBITORS CONTAINING THE SAME
|
|
EP2599776B1
(en)
*
|
2010-07-28 |
2014-10-15 |
Neugen Pharma Inc. |
Therapeutic agent for neurological diseases
|
|
GB2513403A
(en)
*
|
2013-04-26 |
2014-10-29 |
Agency Science Tech & Res |
WNT pathway modulators
|
|
EP2878339A1
(en)
*
|
2013-12-02 |
2015-06-03 |
Siena Biotech S.p.A. |
SIP3 antagonists
|
|
KR20160100407A
(ko)
|
2014-01-06 |
2016-08-23 |
리젠 파마슈티컬스 소시에떼 아노님 |
신규한 글루타미나제의 저해제
|
|
TN2016000542A1
(en)
|
2014-06-03 |
2018-04-04 |
Idorsia Pharmaceuticals Ltd |
Pyrazole compounds and their use as t-type calcium channel blockers
|
|
GB2533421A
(en)
|
2014-12-19 |
2016-06-22 |
Nordic Semiconductor Asa |
Integrated circuits
|
|
US10202376B2
(en)
|
2014-12-24 |
2019-02-12 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
CN104447733B
(zh)
*
|
2015-01-05 |
2016-08-17 |
中国药科大学 |
1-苄基-2-吡咯啉酮-4-酰胺类化合物及其制备方法与应用
|
|
GB201501870D0
(en)
*
|
2015-02-04 |
2015-03-18 |
Cancer Rec Tech Ltd |
Autotaxin inhibitors
|
|
WO2018129381A1
(en)
*
|
2017-01-06 |
2018-07-12 |
Beyondspring Pharmaceuticals, Inc. |
Tubulin binding compounds and therapeutic use thereof
|
|
JP2020523379A
(ja)
|
2017-06-14 |
2020-08-06 |
ヨーロピアン モレキュラー バイオロジー ラボラトリーEuropean Molecular Biology Laboratory |
治療への使用のためのベンゾフランアミドおよびそれらの複素芳香族アナログ
|
|
WO2019046668A1
(en)
|
2017-08-31 |
2019-03-07 |
Kezar Life Sciences |
AMIDE-SUBSTITUTED THIAZOLES AS INHIBITORS OF SECRETIC PROTEIN
|
|
EP3746124A4
(en)
*
|
2018-01-30 |
2021-10-27 |
Foghorn Therapeutics Inc. |
COMPOUNDS AND THEIR USES
|
|
AU2020214308A1
(en)
*
|
2019-01-29 |
2021-08-12 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
CA3128155C
(en)
*
|
2019-01-31 |
2023-09-19 |
Pfizer Inc. |
3-carbonylamino-5-cyclopentyl-1h-pyrazole compounds having inhibitory activity on cdk2
|